Silence Therapeutics plc SLNCF
6.52 USD +0.15 +2.35%
At close · Oct 30
- YTD
- +226.00%
- 1 year
- +262.22%
- Open
- 6.37
- Prev close
- 6.37
- Mkt cap
- 1.22B
- Vol
- 51.77K
- Avg vol
- 4.17K
- EPS
- -0.43
- P/E
- 0.00
More statistics
- Low
- 6.37
- High
- 6.52
MAX chart
Chart tools
Chart is warming up
The all-time price history for SLNCF has not been loaded yet. Try again in a moment.
Altman Z-Score
-3.12 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
P/E -1.1×
P/S 171×
P/B 1.5×
P/FCF -1.5×
EV/EBITDA -1.0×
EV/Sales 151×
FCF Yield -65.1%
Gross Margin 61.5%
Operating Margin -16056.0%
Net Margin -15851.9%
ROE -142.2%
ROIC -76.1%
ROA -67.4%
Revenue -98.7%
Operating Income -41.7%
EPS (diluted) -139.2%
Free Cash Flow -15.0%
Current Ratio 8.7×
Quick Ratio 8.7×
Debt / Equity 0.0×
Net Debt / EBITDA 0.1×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31